CARA

Cara Therapeutics Inc.

Price

return (12m)

p/e

0.00

p/bv

0.00

DIVIDEND YIELD

0.00%

CARA price

Cara Therapeutics

If you had invested

exposure

years ago

ago, you would now have *

today you would have:

*The amount considers the reinvestment of dividends.

Return on Investment CARA

1 month

3 months

1 year

2 years

5 years

10 years

return

1 month

0.00%

3 months

0.00%

1 year

0.00%

2 years

0.00%

5 years

0.00%

10 years

0.00%

Profitability Comparator

If you had invested

years ago

today you would have:

Fundamentals CARA

Valuation

P/E

0.00

Sector 0.83

Industry -1.39

P/BV

0.00

Sector 1.76

Industry 1.20

P/Revenue (PSR)

Sector 1.46

Industry 2.18

EV/EBITDA

0.61

Sector -49.53

Industry -34.65

EV/EBIT

0.60

Sector -44.05

Industry -38.72

P/EBITDA

Sector -31.35

Industry -21.04

P/EBIT

Sector -29.48

Industry -22.62

P/Total Assets

Sector 0.80

Industry 0.69

P/Net Current Assets

0.00

Sector -24.28

Industry -63.40

P/Working Capital

0.00

Sector 2.46

Industry -2.20

EPS

-14.18

Sector -0.70

Industry -1.23

BVPS

-0.92

Sector 4.35

Industry 2.78

Efficiency

Gross Margin

91.32%

Sector 49.06%

Industry 49.71%

EBITDA Margin

-373.97%

Sector -236.78%

Industry -16,811,838.30%

EBIT Margin

-100.00%

Sector -19.73%

Industry -25.36%

Net Profit Margins

-100.00%

Sector -23.90%

Industry -27.40%

Asset Turnover

0.03

Sector 0.13

Industry 0.06

Profitability

ROE

-270.02%

Sector -27.98%

Industry -36.86%

ROA

-83.55%

Sector -23.76%

Industry -44.00%

ROIC

-421.66%

Sector -477.42%

Industry -739.20%

Dividends

Dividend yield

0.00%

Sector -

Industry -

Payout

Sector -

Industry -

Debt

Current Ratio

11.03

Sector 1.92

Industry 2.55

Net Debt / EBITDA

0.61

Sector -21.38

Industry -8.23

Net Debt / EBIT

0.60

Sector -6.88

Industry -36.54

Net Debt / Equity

8.26

Sector -0.58

Industry -1.17

Gross Debt / Equity

0.00

Sector -0.69

Industry -0.54

Equity/Assets

-0.10

Sector 0.46

Industry 0.52

Liabilities/Assets

1.10

Sector 0.49

Industry 0.47

Growth

5Y Revenue CAGR

20.79%

Sector -

Industry -

5Y Earnings CAGR

-4.33%

Sector -

Industry -

Fundamentals CARA

DRAG THE FRAME TO SEE MORE DATA

Assets	Price ($)	Return 12m	DY	P/E	P/BV	ROE	Net Profit Margins
CARA Cara Therapeutics Inc.	$0.00	-	0.00%	0.00	0.00	-270.02%	-100.00%
LLY Eli Lilly and Compay	$1,364.73	51.63%	0.47%	46.01	31.51	86.09%	31.90%
SNY Sanofi	$46.91	-0.71%	3.96%	4.18	0.77	18.43%	14.25%
GSK GlaxoSmithKline PLC	$50.41	12.40%	3.62%	15.22	4.30	30.52%	14.54%
CRMD CorMedix Inc.	$5.23	-54.20%	0.00%	2.52	1.02	54.93%	40.49%
AMPH Amphastar Pharmaceuticals Inc.	$27.66	9.28%	0.00%	15.38	1.57	10.30%	10.76%
RDY Dr. Reddy's Laboratories Ltd.	$14.53	8.60%	0.59%	32.21	2.91	8.97%	10.14%
ENLV Enlivex Therapeutics Ltd.	$1.27	-99.49%	0.00%	0.02	0.01	126.17%	0.00%
JNJ Johnson & Johnson	$272.32	50.49%	1.92%	41.75	8.24	20.02%	16.20%
ISRG Intuitive Surgical Inc.	$468.52	-13.05%	0.00%	52.02	9.66	18.04%	25.64%
NVS Novartis AG	$161.93	32.05%	1.90%	30.66	8.26	24.60%	17.82%
TMO Thermo Fisher Scientific Inc.	$676.94	20.18%	0.26%	36.55	4.73	13.40%	14.97%
ABT Abbott Laboratories	$113.60	-6.41%	2.35%	32.98	0.00	-%	11.52%
MDT Medtronic PLC	$104.84	19.78%	2.94%	23.79	2.45	10.57%	13.93%
CVS CVS Health Corporation	$81.33	7.35%	3.70%	23.54	1.44	6.21%	1.18%
BSX Boston Scientific Corp.	$44.64	-54.86%	0.00%	16.22	0.00	-%	18.14%
TMDX TransMedics Group Inc.	$68.98	-43.56%	0.00%	14.93	4.37	36.28%	22.69%
IDXX IDEXX Laboratories Inc.	$670.71	-7.12%	0.00%	39.02	27.58	74.21%	25.03%
RMD ResMed Inc.	$239.31	-1.85%	1.05%	22.29	5.15	24.27%	26.94%
HCA HCA Healthcare Inc.	$507.48	8.34%	0.65%	14.99	-12.58	-132.40%	8.61%
DHR Danaher Corporation	$226.34	8.23%	0.65%	37.89	3.06	8.27%	16.91%

Stock vs Indice Comparison Tool

If you had invested

years ago

ago, you would now have *

today you would have:

*This calculation reflects price variation only.

CARA - Historical Dividends

no dividend paid in the period.

Current Dividend Yield

0.00%

5-year average Dividend Yield

0.00%

Current Payout

—

5-year average Payout

—

ABOUT Cara Therapeutics

Cara Therapeutics Inc.

Average Investor10 user rating

4.0 (0 people)

United States

22 years

Founded: 2004

2014

Time since IPO - 12 years

80

Employees

Cara Therapeutics Inc. (United States) is listed on the Nasdaq and has a market capitalization of $-, with shareholders equity totaling $-4.59 million.

The company employs approximately 80 people and operates in the Health sector, within the Pharmaceutical Products industry.

Over the past 12 months, Cara Therapeutics Inc. reported $7.14 million in revenue, generating net income of $-70.88 million.

Key financial metrics include a P/E ratio of 0.00, a price-to-book (P/B) ratio of 0.00, and a trailing twelve-month dividend yield of 0.00%.

The company trades under the ticker CARA.

Market cap

Net worth

$-4.59 million

$-4,590,000.00

Assets

$43.83 million

$43,830,000.00

Total Shares Outstanding

5.00 million

5,000,000

Average Daily Trading Volume

$21.89 Thousand

$21,889.56

Sector

Health

Industry

Pharmaceutical Products

CARA

CARA revenue and profits

Financial Results CARA

DRAG THE FRAME TO SEE MORE DATA

CARA cash flow

DRAG THE FRAME TO SEE MORE DATA

Discover more assets

CVS - CVS Health

$81.33 6,56% (12M)

P/E

23.54

3.70%

ROE

6.21%

P/BV

1.44

CI - Cigna

$301.48 20,24% (12M)

P/E

11.53

2.07%

ROE

16.51%

P/BV

1.85

CNC - Centene

$74.17 99,92% (12M)

P/E

-6.50

0.00%

ROE

-20.35%

P/BV

1.46

HUM - Humana

$411.79 66,51% (12M)

P/E

38.53

0.65%

ROE

6.81%

P/BV

2.56

SNY - Sanofi

$46.91 --1,48% (12M)

P/E

4.18

3.96%

ROE

18.43%

P/BV

0.77

JNJ - Johnson & Johnson

$272.32 49,71% (12M)

P/E

41.75

1.92%

ROE

20.02%

P/BV

8.24

LLY - Eli Lilly

$1,364.73 46,68% (12M)

P/E

46.01

0.47%

ROE

86.09%

P/BV

31.51

HCA - HCA Healthcare

$507.48 8,41% (12M)

P/E

14.99

0.65%

ROE

-132.40%

P/BV

-12.58